Reporting and analysis of process-of-care time measures in clinical trials for hyperacute stroke interventions: a scoping review protocol

被引:0
|
作者
Italiano, Dominic [1 ,2 ]
Johns, Hannah [1 ,2 ]
Campbell, Bruce [3 ]
Turc, Guillaume [4 ,5 ,6 ,7 ]
Churilov, Leonid [1 ,2 ]
机构
[1] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia
[2] Royal Melbourne Hosp, Melbourne Brain Ctr, Australian Stroke Alliance, Melbourne, Vic, Australia
[3] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Neurol, Melbourne Brain Ctr, Melbourne, Vic, Australia
[4] GHU Paris Psychiat & Neurosci, Dept Neurol, Paris, France
[5] Univ Paris Cite, Paris, France
[6] Inserm, Paris, France
[7] FHU NeuroVasc, Paris, France
关键词
clinical trials; hyperacute stroke; methodology; scoping reviews; time measures; TENECTEPLASE; THROMBECTOMY; ALTEPLASE;
D O I
10.11124/JBIES-23-00136
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective:The objective of this scoping review is to investigate the reporting and comparison of process-of-care time measures in hyperacute stroke trials and systematic reviews of trials (subsequently referred to as "studies").Introduction:Stroke is a leading cause of death and disability worldwide. A crucial factor in determining the effectiveness of stroke care in improving patient outcomes is time; therefore, time measures are frequently reported in studies of hyperacute stroke interventions. However, there is inconsistency in how these measures are reported and compared. Furthermore, there is a lack of clarity in how compatible the reporting methods are with the statistical analysis methods.Inclusion criteria:This scoping review will include studies that report and/or compare time measures between key events of interest in the delivery of hyperacute stroke care. Studies of thrombolytic therapy and/or thrombectomy, as well as controlled trials of mobile stroke unit interventions, will be included.Methods:The scoping review will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) and the JBI methodology for scoping reviews. The search will be executed in MEDLINE (PubMed), Embase (Ovid), and clinical trial registries ANZCTR, ISRCTN, and ClinicalTrials.gov. Title and abstract screening will be followed by full-text screening and subsequent data extraction from eligible studies. The results from this scoping review will be presented in tables and narratively summarized.Review registration:Open Science Framework https://osf.io/y98wz
引用
收藏
页码:489 / 497
页数:9
相关论文
共 50 条
  • [41] REAL-TIME REPORTING OF CLINICAL PROCESS MEASURES REVEALS IMPROVED PERFORMANCE, YET DIFFERENCES PERSIST BETWEEN HOSPITALS IN THE AUSTRALIAN COOPERATIVE NATIONAL REGISTRY OF ACUTE CORONARY CARE, GUIDELINE ADHERENCE AND CLINICAL EVENTS (CONCORDANCE)
    Aliprandi-Costa, Bernadette
    Brieger, David B.
    West, Sandra
    Gullick, Janice
    Ryan, Estelle
    Turnbull, Rhonda
    Morgan, Carla
    Alford, Kevin
    Kamaldasa, Kanishka
    Ranasinghe, Isuru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A79 - A79
  • [42] The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
    Nielsen, Emil Eik
    Feinberg, Joshua
    Raymond, Ilan
    Olsen, Michael Hecht
    Steensgaard-Hansen, Frank Victor
    Jakobsen, Janus Christian
    SYSTEMATIC REVIEWS, 2019, 8 (01)
  • [43] The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
    Emil Eik Nielsen
    Joshua Feinberg
    Ilan Raymond
    Michael Hecht Olsen
    Frank Victor Steensgaard-Hansen
    Janus Christian Jakobsen
    Systematic Reviews, 8
  • [44] Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol
    Doyle, Frank
    Freedland, Kenneth
    Carney, Robert
    de Jonge, Peter
    Dickens, Chris
    Pedersen, Susanne
    Sorensen, Jan
    Dempster, Martin
    SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [45] Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol
    Frank Doyle
    Kenneth Freedland
    Robert Carney
    Peter de Jonge
    Chris Dickens
    Susanne Pedersen
    Jan Sorensen
    Martin Dempster
    Systematic Reviews, 8
  • [46] The Use of Adjunct Psychosocial Interventions Can Decrease Postoperative Pain and Improve the Quality of Clinical Care in Orthopedic Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Szeverenyi, Csenge
    Kekecs, Zoltan
    Johnson, Alisa
    Elkins, Gary
    Csernatony, Zoltan
    Varga, Katalin
    JOURNAL OF PAIN, 2018, 19 (11): : 1231 - 1252
  • [47] Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
    Christian Ovesen
    Jan Purrucker
    Christian Gluud
    Janus Christian Jakobsen
    Hanne Christensen
    Thorsten Steiner
    Systematic Reviews, 7
  • [48] Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
    Ovesen, Christian
    Purrucker, Jan
    Gluud, Christian
    Jakobsen, Janus Christian
    Christensen, Hanne
    Steiner, Thorsten
    SYSTEMATIC REVIEWS, 2018, 7
  • [49] Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
    Kumar, Gyanendra
    Uhrig, Drew
    Fowler, Susan
    DeLaney, Matthew C.
    Alexandrov, Andrei V.
    CNS DRUGS, 2015, 29 (08) : 659 - 667
  • [50] Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
    Gyanendra Kumar
    Drew Uhrig
    Susan Fowler
    Matthew C. DeLaney
    Andrei V. Alexandrov
    CNS Drugs, 2015, 29 : 659 - 667